Cytokinetics CYTK
NASDAQ CYTK
$65.64 -0.52 (-0.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Gross Margin (2025 - 2026)

Updated

Cytokinetics (CYTK) recorded Gross Margin of 90.46% in Q2 2026, down 9.54 percentage points from 100.00% a year earlier and down 8.71 percentage points from the prior quarter.

Analysis

Cytokinetics (CYTK) Gross Margin (2025 - 2026) Analysis & Trends

On a TTM basis, Cytokinetics' Gross Margin came in at 167.63% as of Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Cytokinetics 9.20 Bn 5.37 Bn 25.89 Mn 90.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.46%
Mar 31, 2026 99.17%
Jun 30, 2025 100.00%
Mar 31, 2025 100.00%
API Access

Cytokinetics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEY